{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:34:47Z","timestamp":1785908087521,"version":"3.56.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bmc.2025.118515","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T23:20:44Z","timestamp":1765063244000},"page":"118515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of quinazoline\u2013benzohydrazide and quinazoline\u2013benzothiazole hybrids uncovering a dual EGFR\/VEGFR-2 inhibitor with pronounced cytotoxic activity against triple-negative breast Cancer"],"prefix":"10.1016","volume":"133","author":[{"given":"Noura F.M.","family":"El Hamaky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Hamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed A.","family":"Bayoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah A.","family":"Elgazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda N.A.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bmc.2025.118515_bb0005","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1186\/s12885-024-12641-8","article-title":"Non-genetic factors and breast cancer: an umbrella review of meta-analyses","volume":"24","author":"Yiallourou","year":"2024","journal-title":"BMC Cancer"},{"issue":"9","key":"10.1016\/j.bmc.2025.118515_bb0010","doi-asserted-by":"crossref","first-page":"731","DOI":"10.20892\/j.issn.2095-3941.2024.0222","article-title":"Evolving molecular subtyping of breast cancer advances precision treatment","volume":"21","author":"Shan","year":"2024","journal-title":"Cancer Biol Med"},{"issue":"3","key":"10.1016\/j.bmc.2025.118515_bb0015","first-page":"287","article-title":"Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN","volume":"5","author":"Zhang","year":"2025","journal-title":"J Natl Cancer Cent"},{"issue":"3","key":"10.1016\/j.bmc.2025.118515_bb0020","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA: Cancer","volume":"74","author":"Bray","year":"2024","journal-title":"J. Clin."},{"issue":"4","key":"10.1016\/j.bmc.2025.118515_bb0025","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/molecules29040875","article-title":"Recent advances in structural optimization of Quinazoline-based protein kinase inhibitors for Cancer therapy (2021-present)","volume":"29","author":"Abdel-Mohsen","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2025.118515_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113300","article-title":"Design, synthesis and biological evaluation of sulfamoylphenyl-quinazoline derivatives as potential EGFR\/CAIX dual inhibitors","volume":"216","author":"Zhang","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118515_bb0035","article-title":"Design and synthesis of novel 2-S-alkylated Quinazolinones as dual BRAFV600E and EGFR inhibitors in melanoma: mechanistic insights from apoptosis and cell cycle modulation","volume":"108526","author":"El-Shafey","year":"2025","journal-title":"Bioorg Chem"},{"issue":"36","key":"10.1016\/j.bmc.2025.118515_bb0040","doi-asserted-by":"crossref","first-page":"26325","DOI":"10.1039\/D4RA04828H","article-title":"S-alkylated quinazolin-4 (3H)-ones as dual EGFR\/VEGFR-2 kinases inhibitors: design, synthesis, anticancer evaluation and docking study","volume":"14","author":"Tawfik","year":"2024","journal-title":"RSC Adv"},{"issue":"6","key":"10.1016\/j.bmc.2025.118515_bb0045","first-page":"3147","article-title":"The story of MCF-7 breast Cancer cell line: 40 years of experience in research","volume":"35","author":"Com\u015fa","year":"2015","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.bmc.2025.118515_bb0050","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13058-024-01796-8","article-title":"Cell morphology best predicts tumorigenicity and metastasis in vivo across multiple TNBC cell lines of different metastatic potential","volume":"26","author":"Conner","year":"2024","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.bmc.2025.118515_bb0055","article-title":"Role of Lactate in the Regulation of Transcriptional Activity of Breast Cancer-Related Genes and Epithelial-to-Mesenchymal Transition Proteins: A Compassion of MCF7 and MDA-MB-231 Cancer Cell Lines","author":"San-Millan","year":"2023","journal-title":"bioRxiv : the preprint server for biology"},{"issue":"5","key":"10.1016\/j.bmc.2025.118515_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25053066","article-title":"Combination treatment with EGFR inhibitor and doxorubicin synergistically inhibits proliferation of MCF-7 cells and MDA-MB-231 triple-negative breast Cancer cells in vitro","volume":"25","author":"Abrahams","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.bmc.2025.118515_bb0065","doi-asserted-by":"crossref","first-page":"139","DOI":"10.20892\/j.issn.2095-3941.2020.0151","article-title":"VEGFR2 inhibition hampers breast cancer cell proliferation via enhanced mitochondrial biogenesis","volume":"18","author":"Ni","year":"2021","journal-title":"Cancer Biol Med"},{"issue":"10","key":"10.1016\/j.bmc.2025.118515_bb0070","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/17568919.2025.2507558","article-title":"Recent advances in the investigation of the quinazoline nucleus and derivatives with potential anticancer activities","volume":"17","author":"Antoniolli","year":"2025","journal-title":"Future Med Chem"},{"issue":"10","key":"10.1016\/j.bmc.2025.118515_bb0075","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3390\/ph18101546","article-title":"Multi-Kinase Inhibition by New Quinazoline\u2013Isatin Hybrids: Design, Synthesis, Biological Evaluation and Mechanistic Studies","volume":"18","author":"Alanazi","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"8","key":"10.1016\/j.bmc.2025.118515_bb0080","doi-asserted-by":"crossref","first-page":"2000068","DOI":"10.1002\/ardp.202000068","article-title":"Design, synthesis, molecular docking, and anticancer evaluations of 1-benzylquinazoline-2, 4 (1H,3H)-dione bearing different moieties as VEGFR-2 inhibitors","volume":"353","author":"El-Adl","year":"2020","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2025.118515_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115872","article-title":"Design, synthesis, and anti-proliferative evaluation of new quinazolin-4(3H)-ones as potential VEGFR-2 inhibitors","volume":"29","author":"El-Adl","year":"2021","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"10.1016\/j.bmc.2025.118515_bb0090","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202200189","article-title":"Biodiversity, design, synthesis and molecular docking of novel Quinazolinone hydrazide derivatives as EGFR inhibitors","volume":"19","author":"Fang","year":"2022","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.bmc.2025.118515_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103726","article-title":"Design and synthesis of some new 2,4,6-trisubstituted quinazoline EGFR inhibitors as targeted anticancer agents","volume":"98","author":"Allam","year":"2020","journal-title":"Bioorg Chem"},{"issue":"18","key":"10.1016\/j.bmc.2025.118515_bb0100","doi-asserted-by":"crossref","first-page":"12184","DOI":"10.1039\/D3RA00416C","article-title":"Novel 4-thiophenyl-pyrazole, pyridine, and pyrimidine derivatives as potential antitumor candidates targeting both EGFR and VEGFR-2; design, synthesis, biological evaluations, and in silico studies","volume":"13","author":"Al-Muntaser","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2025.118515_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.141634","article-title":"Rational design, docking, syntheses, ADMET and cytotoxicity assessments of iodoquinazoline derivatives as inhibitors of EGFRT790M and VEGFR-2","volume":"1331","author":"Aljohani","year":"2025","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2025.118515_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104695","article-title":"Design, synthesis and molecular modeling of new quinazolin-4(3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation","volume":"109","author":"Abdallah","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118515_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134690","article-title":"Discovery of novel thioquinazoline-N-aryl-acetamide\/N-arylacetohydrazide hybrids as anti-SARS-CoV-2 agents: synthesis, in vitro biological evaluation, and molecular docking studies","volume":"1276","author":"Abdel-Mohsen","year":"2023","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2025.118515_bb0120","doi-asserted-by":"crossref","unstructured":"M.M. Al-Sanea, A. Hamdi, A.A.B. Mohamed, H.W. El-Shafey, M. Moustafa, A.A. Elgazar, W.M. Eldehna, H. Ur Rahman, D.G.T. Parambi, R.M. Elbargisy, S. Selim, S.N.A. Bukhari, O. Magdy Hendawy, S.S. Tawfik, New benzothiazole hybrids as potential VEGFR-2 inhibitors: design, synthesis, anticancer evaluation, and in silico study, J Enzyme Inhib Med Chem 38(1) (2023) 2166036.https:\/\/doi.org\/10.1080\/14756366.2023.2166036.","DOI":"10.1080\/14756366.2023.2166036"},{"issue":"21","key":"10.1016\/j.bmc.2025.118515_bb0125","doi-asserted-by":"crossref","first-page":"9966","DOI":"10.3390\/app14219966","article-title":"Beyond the arbitrariness of drug-likeness rules: rough set theory and decision rules in the Service of Drug Design","volume":"14","author":"Miebs","year":"2024","journal-title":"Appl Sci"},{"issue":"11","key":"10.1016\/j.bmc.2025.118515_bb0130","doi-asserted-by":"crossref","first-page":"e202300115","DOI":"10.1002\/minf.202300115","article-title":"Absorption matters: A closer look at popular oral bioavailability rules for drug approvals","volume":"42","author":"Soares","year":"2023","journal-title":"Mol Inform"},{"issue":"2","key":"10.1016\/j.bmc.2025.118515_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28020776","article-title":"Evaluation of free online ADMET tools for academic or small biotech environments","volume":"28","author":"Dulsat","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.bmc.2025.118515_bb0140","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.bmc.2025.118515_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202000907","article-title":"Synthesis, molecular docking and biological evaluation of 2-Aryloxy-N-Phenylacetamide and N'-(2-Aryloxyoxyacetyl) Benzohydrazide derivatives as potential antibacterial agents","volume":"18","author":"Yele","year":"2021","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.bmc.2025.118515_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136675","article-title":"Antimicrobial activity of novel substituted 1,2,4-triazole and 1,3-thiazole derivatives","volume":"1295","author":"Saffour","year":"2024","journal-title":"J Mol Struct"},{"issue":"5","key":"10.1016\/j.bmc.2025.118515_bb0155","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1002\/jhet.3942","article-title":"Turan, synthesis of new benzothiazole derivatives bearing thiadiazole as monoamine oxidase inhibitors","volume":"57","author":"Acar Cevik","year":"2020","journal-title":"J Heterocyclic Chem"},{"issue":"1\u20132","key":"10.1016\/j.bmc.2025.118515_bb0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.bmc.2025.118515_bb0165","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J Immunol Methods"},{"issue":"6","key":"10.1016\/j.bmc.2025.118515_bb0170","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3987\/COM-15-13210","article-title":"Synthesis and anticancer activities of thiazoles, 1, 3-thiazines, and thiazolidine using chitosan-grafted-poly (vinylpyridine) as basic catalyst","volume":"91","author":"Gomha","year":"2015","journal-title":"Heterocycles"},{"key":"10.1016\/j.bmc.2025.118515_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111768","article-title":"3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: synthesis, in vitro biological evaluation and in silico insights","volume":"184","author":"Abo-Ashour","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2025.118515_bb0180","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1080\/14756366.2022.2104841","article-title":"Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer","volume":"37","author":"Abdelsalam","year":"2022","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2025.118515_bb0185","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.2147\/DDDT.S490930","article-title":"Design, synthesis, pharmacological evaluation of Quinazolin-4 (3 H)-ones bearing urea functionality as potential VEGFR-2 inhibitors","author":"Al-Sanea","year":"2024","journal-title":"Drug Des Devel Ther"},{"issue":"5","key":"10.1016\/j.bmc.2025.118515_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.22228","article-title":"Exploring chromone-2-carboxamide derivatives for triple-negative breast cancer targeting EGFR, FGFR3, and VEGF pathways: design, synthesis, and preclinical insights","volume":"85","author":"El-Gamil","year":"2024","journal-title":"Drug Dev Res"},{"issue":"11","key":"10.1016\/j.bmc.2025.118515_bb0195","doi-asserted-by":"crossref","DOI":"10.1101\/pdb.prot087288","article-title":"Quantitation of apoptosis and necrosis by Annexin V binding, Propidium iodide uptake, and flow cytometry","volume":"2016","author":"Crowley","year":"2016","journal-title":"Cold Spring Harb Protoc"},{"key":"10.1016\/j.bmc.2025.118515_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108377","article-title":"New pyrrolo [3, 4-d] isoxazolidines hybrid with furan as antitumor agents and multi-target enzyme inhibitors: synthesis and in silico study","volume":"159","author":"Said","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118515_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109162","article-title":"Exploiting COX-2 engagement for amplifying anticancer potential of Quinazoline-triazole conjugates with superior EGFR\/VEGFR-2 inhibition","volume":"166","author":"Serag","year":"2025","journal-title":"Bioorg Chem"},{"issue":"42","key":"10.1016\/j.bmc.2025.118515_bb0210","doi-asserted-by":"crossref","first-page":"39490","DOI":"10.1021\/acsomega.3c05247","article-title":"3-Acetyl-11-keto-beta-boswellic acid-based hybrids alleviate acetaminophen-induced hepatotoxicity in HepG2 by the regulation of inflammatory and oxidative stress pathways: an integrated approach","volume":"8","author":"Elgazar","year":"2023","journal-title":"ACS Omega"},{"issue":"36","key":"10.1016\/j.bmc.2025.118515_bb0215","doi-asserted-by":"crossref","first-page":"25616","DOI":"10.1039\/D3RA04867E","article-title":"Theophylline-based hybrids as acetylcholinesterase inhibitors endowed with anti-inflammatory activity: synthesis, bioevaluation, in silico and preliminary kinetic studies","volume":"13","author":"Elgazar","year":"2023","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2025.118515_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107437","article-title":"Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: design, synthesis, and molecular docking study","volume":"148","author":"El Hamaky","year":"2024","journal-title":"Bioorg Chem"},{"issue":"13","key":"10.1016\/j.bmc.2025.118515_bb0225","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.3390\/molecules29133186","article-title":"Identification of Benzothiazoles bearing 1,3,4-Thiadiazole as Antiproliferative hybrids targeting VEGFR-2 and BRAF kinase: design, synthesis, BIO evaluation and in silico study","volume":"29","author":"Ewes","year":"2024","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bmc.2025.118515_bb0230","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J Comput Chem"},{"issue":"10","key":"10.1016\/j.bmc.2025.118515_bb0235","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1055\/a-2058-3863","article-title":"Bio-evaluation of untapped alkaloids from Vinca minor enriched by methyl-jasmonate-induced stress: an integrated approach","volume":"89","author":"El-Senduny","year":"2023","journal-title":"Planta Med"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625004572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625004572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T08:38:17Z","timestamp":1781253497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625004572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"alternative-id":["S0968089625004572"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118515","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of quinazoline\u2013benzohydrazide and quinazoline\u2013benzothiazole hybrids uncovering a dual EGFR\/VEGFR-2 inhibitor with pronounced cytotoxic activity against triple-negative breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118515"}}